DUBLIN--(BUSINESS WIRE)--The "Cell Lysis/Cell Fractionation Market Research Report by Product (Consumables and Instruments), Cell Type, Application, End-user, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Cell Lysis/Cell Fractionation Market size was estimated at USD 2,857.61 million in 2021, USD 3,094.01 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 8.44% to reach USD 4,649.13 million by 2027.
In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.
Cumulative Impact of COVID-19:
The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects.
It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cell Lysis/Cell Fractionation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space.
It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors.
The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
- Agilent Technologies
- Beckman Coulter
- Becton, Dickinson and Company
- Bio-Rad Laboratories
- Biovision
- Cell Signaling Technology
- Claremont Biosolutions
- Covaris
- G-Biosciences (Geno Technology)
- Labfreez Instruments Group
- Merck
- Microfluidics International Corporation
- Miltenyi Biotec
- Norgen Biotek Corp.
- Nzytech
- Parr Instrument Company
- Promega Corporation
- Promocell
- Qiagen
- Qsonica
- Roche Diagnostics
- Stemcell Technologies
- Takara Bio
- Thermo Fisher Scientific
Key Topics Covered:
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Expanding healthcare, life sciences, and pharmaceutical industries research and developmental activities in countless fields
5.1.1.2. Increasing government funding for research
5.1.1.3. Increasing cases of diseases and diagnostics
5.1.2. Restraints
5.1.2.1. High cost of cell-based equipments and researches
5.1.2.2. Shortage of trained personnel
5.1.3. Opportunities
5.1.3.1. Growing focus on personalized medicine, and the expansion of biopharmaceutical and biotechnology industries
5.1.3.2. Growing prevalence of diseases such as HIV/AIDS and cancer
5.1.4. Challenges
5.1.4.1. Survival of small players and addition of new technological advancement routinely
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Cell Lysis/Cell Fractionation Market, by Product
6.1. Introduction
6.2. Consumables
6.2.1. Beads
6.2.2. Disposables
6.2.3. Reagents & Kits
6.3. Instruments
6.3.1. Homogenizers
6.3.2. Sonicators
7. Cell Lysis/Cell Fractionation Market, by Cell Type
7.1. Introduction
7.2. Mammalian Cells
7.3. Microbial Cells
8. Cell Lysis/Cell Fractionation Market, by Application
8.1. Introduction
8.2. Nucleic Acid Purification & Isolation
8.3. Protein Purification & Isolation
9. Cell Lysis/Cell Fractionation Market, by End-user
9.1. Introduction
9.2. Biopharmaceutical & Biotechnology Companies
9.3. Research Laboratories & Institutes
10. Americas Cell Lysis/Cell Fractionation Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Cell Lysis/Cell Fractionation Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Cell Lysis/Cell Fractionation Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
For more information about this report visit https://www.researchandmarkets.com/r/4vd7q5
